• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症标志物与帕金森病中的抑郁:系统综述。

Inflammatory markers and depression in Parkinson's disease: a systematic review.

机构信息

Department of Physiology and Pharmacology, Federal University of Santa Maria, 1000 Roraima Avenue, Building 21, Santa Maria, Rio Grande do Sul, Brazil.

Division of Neurology, University Hospital of Santa Maria, Santa Maria, Brazil.

出版信息

Neurol Sci. 2022 Dec;43(12):6707-6717. doi: 10.1007/s10072-022-06363-7. Epub 2022 Aug 30.

DOI:10.1007/s10072-022-06363-7
PMID:36040559
Abstract

BACKGROUND

Parkinson's disease (PD) patients experience non-motor symptoms (NMS), which may appear before motor manifestations. The most common NMS is depression, affecting about 30-40% of PD patients. Both PD and depression are associated with an increased inflammatory burden, with studies showing elevation of diverse inflammatory markers in patients with both conditions.

METHODS

A systematic review was conducted in PubMed and PsycINFO databases to investigate what inflammatory markers are associated with PD depression (PDD). Only studies in English that measured inflammatory markers and analyzed against depression scores in PD patients were included.

RESULTS

A total of 1132 articles were retrieved, and 14 entries were found to be eligible. Twelve were cross-sectional studies, one was a cohort, and one was a non-randomized controlled trial. IL-17A was the only marker strongly associated with PDD, while studies assessing sIL-2R and serum amyloid A found a moderate correlation. C-reactive protein, IL-10, tumor necrosis factor-α, monocyte chemoattractant protein-1, and IL-6 yielded conflicting results. Their possible roles in PDD are discussed. PDD was also related to longer disease duration and other NMS, such as anxiety, fatigue, dementia, REM sleep behavior disorder, and autonomic dysfunction.

CONCLUSION

We suggest that these markers may be used for distinguishing isolated depression from that related to neurodegeneration, especially in individuals that concurrently present with other known prodromal symptoms of PD and other α-synucleinopathies. However, future prospective studies are warranted to confirm this hypothesis.

摘要

背景

帕金森病(PD)患者会出现非运动症状(NMS),这些症状可能在运动表现之前出现。最常见的 NMS 是抑郁症,影响约 30-40%的 PD 患者。PD 和抑郁症都与炎症负担增加有关,研究表明,这两种疾病的患者体内多种炎症标志物水平升高。

方法

在 PubMed 和 PsycINFO 数据库中进行了系统综述,以研究哪些炎症标志物与 PD 伴发的抑郁症(PDD)相关。仅纳入了测量炎症标志物并针对 PD 患者的抑郁评分进行分析的英文研究。

结果

共检索到 1132 篇文章,有 14 项研究符合入选标准。其中 12 项为横断面研究,1 项为队列研究,1 项为非随机对照试验。IL-17A 是唯一与 PDD 强烈相关的标志物,而评估 sIL-2R 和血清淀粉样蛋白 A 的研究发现两者中度相关。C 反应蛋白、IL-10、肿瘤坏死因子-α、单核细胞趋化蛋白-1 和 IL-6 的结果存在矛盾。讨论了它们在 PDD 中的可能作用。PDD 还与疾病持续时间较长和其他 NMS 有关,如焦虑、疲劳、痴呆、快速眼动睡眠行为障碍和自主神经功能障碍。

结论

我们认为这些标志物可用于区分与神经退行性变相关的孤立性抑郁症,特别是在同时存在其他已知 PD 前驱症状和其他 α-突触核蛋白病的个体中。然而,需要进一步的前瞻性研究来验证这一假设。

相似文献

1
Inflammatory markers and depression in Parkinson's disease: a systematic review.炎症标志物与帕金森病中的抑郁:系统综述。
Neurol Sci. 2022 Dec;43(12):6707-6717. doi: 10.1007/s10072-022-06363-7. Epub 2022 Aug 30.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation.肠道生物标志物、微生物群组成以及炎症性肠病的遗传易感性作为帕金森病表现的预测指标。
J Parkinsons Dis. 2025 May 7:1877718X251328567. doi: 10.1177/1877718X251328567.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
6
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.
8
Incidence of antiepileptic drug use in Parkinson's disease.帕金森病中抗癫痫药物的使用发生率。
J Parkinsons Dis. 2025 Jun;15(4):780-788. doi: 10.1177/1877718X251343079. Epub 2025 May 23.
9
Music interventions for improving psychological and physical outcomes in people with cancer.音乐干预对改善癌症患者心理和生理结局的影响。
Cochrane Database Syst Rev. 2021 Oct 12;10(10):CD006911. doi: 10.1002/14651858.CD006911.pub4.
10
Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed methods review.髋、膝或髋膝骨关节炎患者的运动干预和患者信念:一项混合方法综述
Cochrane Database Syst Rev. 2018 Apr 17;4(4):CD010842. doi: 10.1002/14651858.CD010842.pub2.

引用本文的文献

1
Identification and experimental validation of biomarkers associated with mitochondrial and programmed cell death in major depressive disorder.重度抑郁症中与线粒体和程序性细胞死亡相关的生物标志物的鉴定及实验验证
Front Psychiatry. 2025 Apr 30;16:1564380. doi: 10.3389/fpsyt.2025.1564380. eCollection 2025.
2
IGF2-Reprogrammed Macrophages Ameliorate the Inflammatory Response and Protect Against the Neuroinflammatory Process in Parkinson's Disease Models.IGF2重编程巨噬细胞可改善炎症反应并在帕金森病模型中抵御神经炎症过程。
Aging Cell. 2025 Jun;24(6):e70020. doi: 10.1111/acel.70020. Epub 2025 Mar 27.
3
Correlation of inflammatory markers with depression and sleep disorders accompanying the prodromal stage of Parkinson's disease.

本文引用的文献

1
Azathioprine immunosuppression and disease modification in Parkinson's disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol.硫唑嘌呤免疫抑制和帕金森病的疾病修饰(AZA-PD):一项随机、双盲、安慰剂对照的 II 期试验方案。
BMJ Open. 2020 Nov 23;10(11):e040527. doi: 10.1136/bmjopen-2020-040527.
2
Parkinson's Disease With Depression: The Correlations Between Neuroinflammatory Factors and Neurotransmitters in Cerebrospinal Fluid.帕金森病伴发抑郁:脑脊液中神经炎症因子与神经递质的相关性
Front Aging Neurosci. 2020 Oct 23;12:574776. doi: 10.3389/fnagi.2020.574776. eCollection 2020.
3
帕金森病前驱期炎症标志物与抑郁及睡眠障碍的相关性
World J Psychiatry. 2025 Mar 19;15(3):99901. doi: 10.5498/wjp.v15.i3.99901.
4
Identification of Age and Underlying Disease Characteristics in Patients with Mild to Moderate Depression Comorbid with Parkinson's Disease: A Retrospective Case-control Study.轻度至中度抑郁症合并帕金森病患者的年龄及基础疾病特征识别:一项回顾性病例对照研究
Actas Esp Psiquiatr. 2025 Mar;53(2):331-339. doi: 10.62641/aep.v53i2.1702.
5
P1 evoked by facial expression images is enhanced in Parkinson's disease patients with depressive symptoms.伴有抑郁症状的帕金森病患者中,由面部表情图像诱发的P1增强。
Front Aging Neurosci. 2024 Oct 30;16:1423875. doi: 10.3389/fnagi.2024.1423875. eCollection 2024.
6
Associations Between Neuropsychiatric Symptoms and Inflammation in Neurodegenerative Dementia: A Systematic Review.神经退行性痴呆中神经精神症状与炎症之间的关联:一项系统综述
J Inflamm Res. 2024 Sep 7;17:6113-6141. doi: 10.2147/JIR.S385825. eCollection 2024.
7
The Protection of EGCG Against 6-OHDA-Induced Oxidative Damage by Regulating PPARγ and Nrf2/HO-1 Signaling.表没食子儿茶素没食子酸酯通过调节过氧化物酶体增殖物激活受体γ和核因子E2相关因子2/血红素加氧酶-1信号通路对6-羟基多巴胺诱导的氧化损伤的保护作用
Nutr Metab Insights. 2024 May 25;17:11786388241253436. doi: 10.1177/11786388241253436. eCollection 2024.
8
Effect of Butylphthalide soft capsules on cognitive function and dementia-related factors in elderly patients with Parkinson's disease dementia during the COVID-19 pandemic.丁苯酞软胶囊对新型冠状病毒肺炎大流行期间老年帕金森病痴呆患者认知功能及痴呆相关因素的影响
Am J Transl Res. 2024 Feb 15;16(2):496-505. doi: 10.62347/ZIPJ6525. eCollection 2024.
9
Inflammation and Neurodegeneration in Glaucoma: Isolated Eye Disease or a Part of a Systemic Disorder? - Serum Proteomic Analysis.青光眼的炎症与神经退行性变:孤立性眼病还是全身性疾病的一部分?——血清蛋白质组学分析
J Inflamm Res. 2024 Feb 13;17:1021-1037. doi: 10.2147/JIR.S434989. eCollection 2024.
10
Effect of Transcranial Direct Current Stimulation (tDCS) on Depression in Parkinson's Disease-A Narrative Review.经颅直流电刺激(tDCS)对帕金森病抑郁的影响——一项叙述性综述
J Clin Med. 2024 Jan 25;13(3):699. doi: 10.3390/jcm13030699.
Efficacy of pramipexole combined with levodopa for Parkinson's disease treatment and their effects on QOL and serum TNF- levels.
普拉克索联合左旋多巴治疗帕金森病的疗效及其对生活质量和血清肿瘤坏死因子水平的影响。
J Int Med Res. 2020 Jul;48(7):300060520922449. doi: 10.1177/0300060520922449.
4
Melatonin supplementation and the effects on clinical and metabolic status in Parkinson's disease: A randomized, double-blind, placebo-controlled trial.褪黑素补充与帕金森病临床和代谢状态的影响:一项随机、双盲、安慰剂对照试验。
Clin Neurol Neurosurg. 2020 Aug;195:105878. doi: 10.1016/j.clineuro.2020.105878. Epub 2020 May 1.
5
The cytokine IL-17A as a marker of treatment resistance in major depressive disorder?细胞因子白细胞介素-17A 是否可作为重度抑郁症治疗抵抗的标志物?
Eur J Neurosci. 2021 Jan;53(1):172-182. doi: 10.1111/ejn.14636. Epub 2019 Dec 19.
6
High ultrasensitive serum C-reactive protein may be related to freezing of gait in Parkinson's disease patients.高敏血清 C 反应蛋白可能与帕金森病患者的冻结步态有关。
J Neural Transm (Vienna). 2019 Dec;126(12):1599-1608. doi: 10.1007/s00702-019-02096-8. Epub 2019 Oct 31.
7
Drug Choices and Advancements for Managing Depression in Parkinson's Disease.治疗帕金森病相关抑郁的药物选择和进展。
Curr Neuropharmacol. 2020;18(4):277-287. doi: 10.2174/1570159X17666191016094857.
8
Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson's Disease.血浆 IL-6 和 IL-17A 与帕金森病运动和非运动症状的严重程度相关。
J Parkinsons Dis. 2019;9(4):705-709. doi: 10.3233/JPD-191699.
9
Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of Parkinson's disease.MCP-1 和 CCR2 基因多态性与帕金森病风险的关联。
J Neural Transm (Vienna). 2019 Nov;126(11):1465-1470. doi: 10.1007/s00702-019-02072-2. Epub 2019 Aug 30.
10
IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.IL-17A 通过激活帕金森病啮齿动物模型中的小胶质细胞加剧神经炎症和神经退行性变。
Brain Behav Immun. 2019 Oct;81:630-645. doi: 10.1016/j.bbi.2019.07.026. Epub 2019 Jul 24.